Filing Details
- Accession Number:
- 0001179110-14-002075
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-05 18:02:37
- Reporting Period:
- 2014-02-03
- Filing Date:
- 2014-02-05
- Accepted Time:
- 2014-02-05 18:02:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1113481 | Medicines Co | MDCO | Pharmaceutical Preparations (2834) | 043324394 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1204787 | Clive Meanwell | 8 Sylvan Way Parsippany NJ 07054 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-02-03 | 10,000 | $34.29 | 287,773 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The common stock sales were effected pursuant to a Rule 10b5-1 program adopted by Dr. Meanwell on October 25, 2013.
- Represents the weighted average sales price of the shares sold ranging from a low of $33.75 to a high of $34.82 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.